{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:02:29Z","timestamp":1753891349959,"version":"3.41.2"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Micro-invasive glaucoma surgery involves a group of treatment methods associated with a low rate of side effects and good effectiveness outcomes. One of the most frequently performed procedures belonging to this group is iStent microstent implantation. The aim of this study was to perform a retrospective evaluation of the safety and efficacy of a combined procedure involving cataract phacoemulsification and single iStent microstent implantation, performed simultaneously.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The complete medical records of 62 patients (91 eyes) were analyzed retrospectively, including the best corrected visual acuity, intraocular pressure, the mean defect of visual fields, and the number of active substances used in eye drops. The follow-up times were 1, 3, 6, 9, and 12 months after the surgical procedure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A significant improvement in the best corrected visual acuity and a reduction of the intraocular pressure were achieved after the surgery. On average, after 12 months, the best corrected visual acuity improved from 0.70 (0.25) to 0.91 (0.18; <jats:italic>p<\/jats:italic> = 0.001), the intraocular pressure reduced from 17.76 (3.95) to 14.91 (3.04; <jats:italic>p<\/jats:italic> = 0.0001), and the number of active substances used in eye drops reduced from 2.07 (1.08) to 0.70 (0.06; <jats:italic>p<\/jats:italic> = 0001). In addition, we found that patients who initially showed higher intraocular pressure values did not benefit from surgery in the aspect of the number of active substances used in their eye drops. Intraoperative and postoperative adverse events were transient and ultimately did not affect the outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Simultaneous cataract phacoemulsification with single iStent implantation in patients with open-angle glaucoma is a safe and effective method for reducing intraocular pressure and the number of topical medications that must be used. Having initially higher intraocular pressure values may limit the beneficial effects of iStent implantation by subordinating patients from topical treatment; thus, single iStent implantation may not be the most favorable choice in uncontrolled glaucoma cases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1273889","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T11:54:52Z","timestamp":1700740492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness and safety of one-stage iStent-based micro-invasive glaucoma surgery\u2014A retrospective study"],"prefix":"10.3389","volume":"10","author":[{"given":"Marta","family":"Hajduga-Szewczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Smedowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Filipecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Mrukwa-Kominek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003","article-title":"Chapter 3: treatment principles and options supported by the EGS foundation: part 1: foreword; introduction; glossary; chapter 3 treatment principles and options","volume":"101","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10384-020-00736-1","article-title":"What is glaucomatous optic neuropathy?","volume":"64","author":"Nakazawa","year":"2020","journal-title":"Jap. J. Ophthalmol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","article-title":"Glaucoma: the retina and beyond","volume":"132","author":"Davis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC Li","year":"2014","journal-title":"Ophthalmology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archophthalmol.2010.196","article-title":"Canadian glaucoma study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change","volume":"128","author":"Canadian","year":"2010","journal-title":"Archi Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1167\/iovs.09-3806","article-title":"Visual field progression differences between normal-tension and exfoliative high-tension glaucoma","volume":"51","author":"Ahrlich","year":"2010","journal-title":"Inv Ophthalmol Visual Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajo.2007.09.038","article-title":"visual field index for calculation of glaucoma rate of progression","volume":"145","author":"Bengtsson","year":"2008","journal-title":"Am J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","article-title":"Lifetime risk of blindness in open-angle glaucoma","volume":"156","author":"Peters","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ophtha.2008.02.005","article-title":"A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients","volume":"115","author":"Heijl","year":"2008","journal-title":"Ophthalmology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review","volume":"52","author":"Conlon","year":"2017","journal-title":"Can J Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/14656566.2017.1328498","article-title":"Topical treatment of glaucoma: established and emerging pharmacology","volume":"18","author":"Dikopf","year":"2017","journal-title":"Expert Opin Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","article-title":"Updates on the diagnosis and management of glaucoma","volume":"6","author":"Wagner","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.3390\/jcm11226833","article-title":"Minimally invasive glaucoma surgery: safety of individual devices","volume":"11","author":"Rowson","year":"2022","journal-title":"J Clin Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2021.1903513","article-title":"Microinvasive glaucoma surgery: an evidence-based review","volume":"36","author":"Birnbaum","year":"2021","journal-title":"Semin Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/APO.0000000000000561","article-title":"Minimally invasive glaucoma surgery in primary angle-closure glaucoma","volume":"11","author":"Song","year":"2022","journal-title":"The Asia-Pacific J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/ICU.0000000000000936","article-title":"New glaucoma drainage implants available to glaucoma surgeons","volume":"34","author":"Khodeiry","year":"2023","journal-title":"Curr Opin Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"0183142","DOI":"10.1371\/journal.pone.0183142","article-title":"Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis","volume":"12","author":"Lavia","year":"2017","journal-title":"PLoS ONE."},{"volume-title":"Minimally Invasive Glaucoma Surgery","year":"2023","author":"Gurnani","key":"B22"},{"key":"B23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/ICU.0000000000000923","article-title":"Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification","volume":"34","author":"Aref","year":"2023","journal-title":"Curr Opin Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2012.10.017","article-title":"Risk of endophthalmitis and other long-term complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS)","volume":"155","author":"Zahid","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","article-title":"Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS)","volume":"140","author":"Jampel","year":"2005","journal-title":"Am J Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27834","DOI":"10.7759\/cureus.27834","article-title":"Trabeculectomy: Does it have a future?","volume":"14","author":"Rao","year":"2022","journal-title":"Cureus"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/eye.2016.139","article-title":"Manchester iStent study: 3-year results and cost analysis","volume":"30","author":"Tan","year":"2016","journal-title":"Eye."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2018.4461","article-title":"Ocular antihypertensive medication use after iStent implantation concurrent with cataract surgery vs cataract surgery alone in a large US health care claims database","volume":"137","author":"Wang","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1167\/iovs.09-3972","article-title":"Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics","volume":"51","author":"Fern\u00e1ndez-Barrientos","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1155\/2015\/795357","article-title":"Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up","volume":"2015","author":"Fea","year":"2015","journal-title":"J Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/bjophthalmol-2011-300218","article-title":"Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study","volume":"96","author":"Arriola-Villalobos","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/112067210901900311","article-title":"Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery","volume":"19","author":"Spiegel","year":"2009","journal-title":"Eur J Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.ijg.0000435773.20279.56","article-title":"Refractive outcomes of combined cataract and glaucoma surgery","volume":"24","author":"Tzu","year":"2015","journal-title":"J Glaucoma."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0131770","DOI":"10.1371\/journal.pone.0131770","article-title":"iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis","volume":"10","author":"Malvankar-Mehta","year":"2015","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","article-title":"Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract","volume":"118","author":"Samuelson","year":"2011","journal-title":"Ophthalmology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jcrs.2012.07.017","article-title":"Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma","volume":"38","author":"Belovay","year":"2012","journal-title":"J Cataract Refract Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40662-021-00263-1","article-title":"Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results","volume":"8","author":"Salimi","year":"2021","journal-title":"Eye Vision."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1007\/s12325-022-02207-0","article-title":"iStent trabecular micro-bypass stent implantation combined with phacoemulsification for open-angle glaucoma: a 2-year post-marketing surveillance study in Japan","volume":"39","author":"Inatani","year":"2022","journal-title":"Adv Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/OPTH.S293637","article-title":"Treatment of open-angle glaucoma with istent implantation combined with phacoemulsification in polish Caucasian population","volume":"15","author":"Kozera","year":"2021","journal-title":"Clinical Ophthalmology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/08820538.2013.874466","article-title":"Combined non-penetrating deep sclerectomy with phacoemulsification versus non-penetrating deep sclerectomy alone","volume":"29","author":"Bilgin","year":"2014","journal-title":"Semin Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/OPTH.S15025","article-title":"One-year analysis of the iStent trabecular microbypass in secondary glaucoma","volume":"5","author":"Buchacra","year":"2011","journal-title":"Clin Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamaophthalmol.2017.5849","article-title":"Cataract surgery outcomes in eyes with primary epiretinal membrane","volume":"136","author":"Hardin","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1136\/bjo.2009.163923","article-title":"Postoperative infection in penetrating versus non-penetrating glaucoma surgery","volume":"94","author":"Ang","year":"2010","journal-title":"Br J Ophthalmol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajo.2013.03.022","article-title":"Incidence and progression of epiretinal membranes in eyes after cataract surgery","volume":"156","author":"Fong","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"14227","DOI":"10.1111\/ceo.14227","article-title":"Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye","volume":"27","author":"Kiessling","year":"2023","journal-title":"Clin Exp Ophthalmol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy","volume":"53","author":"Schwartz","year":"2008","journal-title":"Surv Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2147\/OPTH.S96695","article-title":"Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication","volume":"9","author":"Katz","year":"2015","journal-title":"Clin Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ophtha.2007.10.004","article-title":"Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines","volume":"115","author":"Stewart","year":"2008","journal-title":"Ophthalmology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the glaucoma adherence and persistency study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Inv Ophthal Visual Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","article-title":"Effectiveness and safety of iStent infinite trabecular micro-bypass for uncontrolled glaucoma","volume":"32","author":"Sarkisian","year":"2023","journal-title":"J Glaucoma."},{"key":"B51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2018.04.001","article-title":"The coma in glaucoma: Retinal ganglion cell dysfunction and recovery","volume":"65","author":"Fry","year":"2018","journal-title":"Prog Retin Eye Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ophtha.2004.09.002","article-title":"Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study","volume":"112","author":"Ventura","year":"2005","journal-title":"Ophthalmology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1167\/iovs.11-8525","article-title":"Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma","volume":"53","author":"Ventura","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS) 7: the relationship between control of intraocular pressure and visual field deterioration","volume":"30","author":"Agis","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12325-018-0666-4","article-title":"Prospective evaluation of two iStent\u00ae trabecular stents, one iStent Supra\u00ae suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes","volume":"35","author":"Myers","year":"2018","journal-title":"Adv Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1273889\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T11:54:55Z","timestamp":1700740495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1273889\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":55,"alternative-id":["10.3389\/fmed.2023.1273889"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1273889","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1273889"}}